nodes	percent_of_prediction	percent_of_DWPC	metapath
Clomipramine—ALB—Furosemide—dilated cardiomyopathy	0.149	0.379	CbGbCtD
Clomipramine—ABCB1—Lisinopril—dilated cardiomyopathy	0.129	0.33	CbGbCtD
Clomipramine—ABCB1—Spironolactone—dilated cardiomyopathy	0.114	0.291	CbGbCtD
Clomipramine—HTR2B—cardial valve—dilated cardiomyopathy	0.0457	0.4	CbGeAlD
Clomipramine—SLC6A2—sympathetic nervous system—dilated cardiomyopathy	0.016	0.14	CbGeAlD
Clomipramine—HTR2A—pulmonary artery—dilated cardiomyopathy	0.00988	0.0866	CbGeAlD
Clomipramine—HTR2A—sympathetic nervous system—dilated cardiomyopathy	0.00961	0.0842	CbGeAlD
Clomipramine—GSTP1—cardiac ventricle—dilated cardiomyopathy	0.00466	0.0409	CbGeAlD
Clomipramine—GSTP1—myocardium—dilated cardiomyopathy	0.00439	0.0384	CbGeAlD
Clomipramine—HRH2—heart—dilated cardiomyopathy	0.00425	0.0373	CbGeAlD
Clomipramine—Trifluoperazine—TNNC1—dilated cardiomyopathy	0.0039	0.649	CrCbGaD
Clomipramine—HRH2—cardiac atrium—dilated cardiomyopathy	0.00364	0.0319	CbGeAlD
Clomipramine—Flat affect—Furosemide—dilated cardiomyopathy	0.00325	0.00881	CcSEcCtD
Clomipramine—Sleep disturbance—Lisinopril—dilated cardiomyopathy	0.00313	0.0085	CcSEcCtD
Clomipramine—GSTP1—heart—dilated cardiomyopathy	0.00306	0.0268	CbGeAlD
Clomipramine—Inappropriate antidiuretic hormone secretion—Lisinopril—dilated cardiomyopathy	0.00302	0.00819	CcSEcCtD
Clomipramine—Ataxia—Spironolactone—dilated cardiomyopathy	0.00294	0.00796	CcSEcCtD
Clomipramine—Nephrolithiasis—Furosemide—dilated cardiomyopathy	0.00291	0.0079	CcSEcCtD
Clomipramine—Glycosuria—Furosemide—dilated cardiomyopathy	0.00289	0.00783	CcSEcCtD
Clomipramine—Psoriasis—Lisinopril—dilated cardiomyopathy	0.00279	0.00758	CcSEcCtD
Clomipramine—Gastritis—Spironolactone—dilated cardiomyopathy	0.00276	0.00749	CcSEcCtD
Clomipramine—Disturbance in attention—Furosemide—dilated cardiomyopathy	0.0027	0.00733	CcSEcCtD
Clomipramine—Eosinophilia—Spironolactone—dilated cardiomyopathy	0.00267	0.00725	CcSEcCtD
Clomipramine—ALB—heart—dilated cardiomyopathy	0.00262	0.023	CbGeAlD
Clomipramine—GSTP1—cardiac atrium—dilated cardiomyopathy	0.00262	0.023	CbGeAlD
Clomipramine—Bone marrow depression—Lisinopril—dilated cardiomyopathy	0.0026	0.00705	CcSEcCtD
Clomipramine—HTR2B—heart—dilated cardiomyopathy	0.00253	0.0221	CbGeAlD
Clomipramine—Hyperuricaemia—Furosemide—dilated cardiomyopathy	0.00252	0.00684	CcSEcCtD
Clomipramine—Gout—Furosemide—dilated cardiomyopathy	0.00251	0.0068	CcSEcCtD
Clomipramine—Erectile dysfunction—Spironolactone—dilated cardiomyopathy	0.00249	0.00674	CcSEcCtD
Clomipramine—Laryngitis—Lisinopril—dilated cardiomyopathy	0.00244	0.00661	CcSEcCtD
Clomipramine—Drowsiness—Spironolactone—dilated cardiomyopathy	0.00241	0.00653	CcSEcCtD
Clomipramine—Blood uric acid increased—Furosemide—dilated cardiomyopathy	0.00238	0.00646	CcSEcCtD
Clomipramine—Haemoptysis—Lisinopril—dilated cardiomyopathy	0.00237	0.00643	CcSEcCtD
Clomipramine—Ventricular fibrillation—Lisinopril—dilated cardiomyopathy	0.00229	0.00622	CcSEcCtD
Clomipramine—Otitis media—Lisinopril—dilated cardiomyopathy	0.00226	0.00612	CcSEcCtD
Clomipramine—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.00225	0.00609	CcSEcCtD
Clomipramine—Memory impairment—Lisinopril—dilated cardiomyopathy	0.00224	0.00607	CcSEcCtD
Clomipramine—Cramps of lower extremities—Furosemide—dilated cardiomyopathy	0.00215	0.00583	CcSEcCtD
Clomipramine—Endocrine disorder—Lisinopril—dilated cardiomyopathy	0.00212	0.00574	CcSEcCtD
Clomipramine—Bladder pain—Furosemide—dilated cardiomyopathy	0.00212	0.00574	CcSEcCtD
Clomipramine—Urine output increased—Furosemide—dilated cardiomyopathy	0.00212	0.00574	CcSEcCtD
Clomipramine—Mental disability—Furosemide—dilated cardiomyopathy	0.00203	0.00551	CcSEcCtD
Clomipramine—Breast pain—Lisinopril—dilated cardiomyopathy	0.00201	0.00546	CcSEcCtD
Clomipramine—Thrombophlebitis—Furosemide—dilated cardiomyopathy	0.00196	0.00532	CcSEcCtD
Clomipramine—Diabetes mellitus—Furosemide—dilated cardiomyopathy	0.00195	0.0053	CcSEcCtD
Clomipramine—Polyuria—Furosemide—dilated cardiomyopathy	0.00194	0.00525	CcSEcCtD
Clomipramine—Photosensitivity—Furosemide—dilated cardiomyopathy	0.00194	0.00525	CcSEcCtD
Clomipramine—Arthropathy—Lisinopril—dilated cardiomyopathy	0.00193	0.00524	CcSEcCtD
Clomipramine—Alopecia—Spironolactone—dilated cardiomyopathy	0.00191	0.00518	CcSEcCtD
Clomipramine—Oliguria—Lisinopril—dilated cardiomyopathy	0.00191	0.00517	CcSEcCtD
Clomipramine—Vascular purpura—Furosemide—dilated cardiomyopathy	0.0019	0.00515	CcSEcCtD
Clomipramine—Deafness—Furosemide—dilated cardiomyopathy	0.0019	0.00515	CcSEcCtD
Clomipramine—Gout—Lisinopril—dilated cardiomyopathy	0.00188	0.0051	CcSEcCtD
Clomipramine—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.00181	0.0049	CcSEcCtD
Clomipramine—Thirst—Furosemide—dilated cardiomyopathy	0.00179	0.00484	CcSEcCtD
Clomipramine—Purpura—Furosemide—dilated cardiomyopathy	0.00176	0.00478	CcSEcCtD
Clomipramine—Ventricular tachycardia—Lisinopril—dilated cardiomyopathy	0.00176	0.00476	CcSEcCtD
Clomipramine—Anaphylactoid reaction—Furosemide—dilated cardiomyopathy	0.00176	0.00476	CcSEcCtD
Clomipramine—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.00175	0.00473	CcSEcCtD
Clomipramine—Cystitis noninfective—Lisinopril—dilated cardiomyopathy	0.00172	0.00465	CcSEcCtD
Clomipramine—Salivary hypersecretion—Lisinopril—dilated cardiomyopathy	0.00171	0.00463	CcSEcCtD
Clomipramine—Malaise—Spironolactone—dilated cardiomyopathy	0.0017	0.0046	CcSEcCtD
Clomipramine—Cystitis—Lisinopril—dilated cardiomyopathy	0.0017	0.0046	CcSEcCtD
Clomipramine—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00168	0.00457	CcSEcCtD
Clomipramine—Photophobia—Lisinopril—dilated cardiomyopathy	0.00165	0.00447	CcSEcCtD
Clomipramine—Neuropathy—Lisinopril—dilated cardiomyopathy	0.00165	0.00447	CcSEcCtD
Clomipramine—Irritability—Furosemide—dilated cardiomyopathy	0.00162	0.0044	CcSEcCtD
Clomipramine—Urinary retention—Furosemide—dilated cardiomyopathy	0.00162	0.00438	CcSEcCtD
Clomipramine—Bladder pain—Lisinopril—dilated cardiomyopathy	0.00159	0.00431	CcSEcCtD
Clomipramine—ADRA2A—heart—dilated cardiomyopathy	0.00159	0.0139	CbGeAlD
Clomipramine—Discomfort—Spironolactone—dilated cardiomyopathy	0.00158	0.00429	CcSEcCtD
Clomipramine—Dehydration—Furosemide—dilated cardiomyopathy	0.00158	0.00428	CcSEcCtD
Clomipramine—Orthostatic hypotension—Furosemide—dilated cardiomyopathy	0.00155	0.00421	CcSEcCtD
Clomipramine—Confusional state—Spironolactone—dilated cardiomyopathy	0.00155	0.0042	CcSEcCtD
Clomipramine—Hypokalaemia—Furosemide—dilated cardiomyopathy	0.00155	0.00419	CcSEcCtD
Clomipramine—Hypertonia—Lisinopril—dilated cardiomyopathy	0.00154	0.00417	CcSEcCtD
Clomipramine—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.00154	0.00416	CcSEcCtD
Clomipramine—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.0015	0.00408	CcSEcCtD
Clomipramine—Muscular weakness—Furosemide—dilated cardiomyopathy	0.0015	0.00406	CcSEcCtD
Clomipramine—Sleep disorder—Lisinopril—dilated cardiomyopathy	0.00147	0.00399	CcSEcCtD
Clomipramine—Diabetes mellitus—Lisinopril—dilated cardiomyopathy	0.00147	0.00397	CcSEcCtD
Clomipramine—Eosinophilia—Furosemide—dilated cardiomyopathy	0.00145	0.00394	CcSEcCtD
Clomipramine—Photosensitivity—Lisinopril—dilated cardiomyopathy	0.00145	0.00394	CcSEcCtD
Clomipramine—Eczema—Lisinopril—dilated cardiomyopathy	0.00142	0.00385	CcSEcCtD
Clomipramine—Somnolence—Spironolactone—dilated cardiomyopathy	0.00136	0.0037	CcSEcCtD
Clomipramine—Pollakiuria—Furosemide—dilated cardiomyopathy	0.00136	0.00368	CcSEcCtD
Clomipramine—ADRA2A—cardiac atrium—dilated cardiomyopathy	0.00136	0.0119	CbGeAlD
Clomipramine—HTR2A—heart—dilated cardiomyopathy	0.00135	0.0118	CbGeAlD
Clomipramine—Photosensitivity reaction—Furosemide—dilated cardiomyopathy	0.00134	0.00363	CcSEcCtD
Clomipramine—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00133	0.00359	CcSEcCtD
Clomipramine—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.00132	0.00359	CcSEcCtD
Clomipramine—Anaphylactoid reaction—Lisinopril—dilated cardiomyopathy	0.00132	0.00357	CcSEcCtD
Clomipramine—Drowsiness—Furosemide—dilated cardiomyopathy	0.00131	0.00355	CcSEcCtD
Clomipramine—Cerebrovascular accident—Lisinopril—dilated cardiomyopathy	0.0013	0.00353	CcSEcCtD
Clomipramine—Diplopia—Lisinopril—dilated cardiomyopathy	0.00128	0.00346	CcSEcCtD
Clomipramine—Osteoarthritis—Lisinopril—dilated cardiomyopathy	0.00128	0.00346	CcSEcCtD
Clomipramine—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00127	0.00343	CcSEcCtD
Clomipramine—Sweating—Furosemide—dilated cardiomyopathy	0.00126	0.0034	CcSEcCtD
Clomipramine—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.00124	0.00336	CcSEcCtD
Clomipramine—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.00122	0.00331	CcSEcCtD
Clomipramine—Urticaria—Spironolactone—dilated cardiomyopathy	0.00122	0.00331	CcSEcCtD
Clomipramine—Irritability—Lisinopril—dilated cardiomyopathy	0.00122	0.0033	CcSEcCtD
Clomipramine—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00121	0.00329	CcSEcCtD
Clomipramine—Cardiac arrest—Lisinopril—dilated cardiomyopathy	0.00121	0.00329	CcSEcCtD
Clomipramine—Ataxia—Lisinopril—dilated cardiomyopathy	0.0012	0.00325	CcSEcCtD
Clomipramine—Dehydration—Lisinopril—dilated cardiomyopathy	0.00119	0.00321	CcSEcCtD
Clomipramine—Orthostatic hypotension—Lisinopril—dilated cardiomyopathy	0.00116	0.00316	CcSEcCtD
Clomipramine—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.00116	0.00315	CcSEcCtD
Clomipramine—Urethral disorder—Furosemide—dilated cardiomyopathy	0.00115	0.00312	CcSEcCtD
Clomipramine—Breast disorder—Lisinopril—dilated cardiomyopathy	0.00115	0.00312	CcSEcCtD
Clomipramine—Visual impairment—Furosemide—dilated cardiomyopathy	0.00113	0.00307	CcSEcCtD
Clomipramine—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00113	0.00307	CcSEcCtD
Clomipramine—Gastritis—Lisinopril—dilated cardiomyopathy	0.00113	0.00306	CcSEcCtD
Clomipramine—Eye disorder—Furosemide—dilated cardiomyopathy	0.0011	0.00298	CcSEcCtD
Clomipramine—Tinnitus—Furosemide—dilated cardiomyopathy	0.0011	0.00297	CcSEcCtD
Clomipramine—Eosinophilia—Lisinopril—dilated cardiomyopathy	0.00109	0.00296	CcSEcCtD
Clomipramine—Pruritus—Spironolactone—dilated cardiomyopathy	0.00109	0.00294	CcSEcCtD
Clomipramine—Bronchospasm—Lisinopril—dilated cardiomyopathy	0.00108	0.00294	CcSEcCtD
Clomipramine—Sweating increased—Lisinopril—dilated cardiomyopathy	0.00107	0.00291	CcSEcCtD
Clomipramine—Angiopathy—Furosemide—dilated cardiomyopathy	0.00107	0.00289	CcSEcCtD
Clomipramine—Immune system disorder—Furosemide—dilated cardiomyopathy	0.00106	0.00288	CcSEcCtD
Clomipramine—Bronchitis—Lisinopril—dilated cardiomyopathy	0.00106	0.00287	CcSEcCtD
Clomipramine—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00105	0.00285	CcSEcCtD
Clomipramine—Arrhythmia—Furosemide—dilated cardiomyopathy	0.00105	0.00285	CcSEcCtD
Clomipramine—Pancytopenia—Lisinopril—dilated cardiomyopathy	0.00105	0.00284	CcSEcCtD
Clomipramine—Dysuria—Lisinopril—dilated cardiomyopathy	0.00103	0.00279	CcSEcCtD
Clomipramine—Malnutrition—Furosemide—dilated cardiomyopathy	0.00102	0.00277	CcSEcCtD
Clomipramine—Dizziness—Spironolactone—dilated cardiomyopathy	0.00102	0.00275	CcSEcCtD
Clomipramine—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.00101	0.00275	CcSEcCtD
Clomipramine—Flatulence—Furosemide—dilated cardiomyopathy	0.00101	0.00273	CcSEcCtD
Clomipramine—Photosensitivity reaction—Lisinopril—dilated cardiomyopathy	0.00101	0.00273	CcSEcCtD
Clomipramine—Weight increased—Lisinopril—dilated cardiomyopathy	0.001	0.00272	CcSEcCtD
Clomipramine—Dysgeusia—Furosemide—dilated cardiomyopathy	0.001	0.00272	CcSEcCtD
Clomipramine—Weight decreased—Lisinopril—dilated cardiomyopathy	0.000997	0.0027	CcSEcCtD
Clomipramine—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.000994	0.0027	CcSEcCtD
Clomipramine—Pneumonia—Lisinopril—dilated cardiomyopathy	0.000988	0.00268	CcSEcCtD
Clomipramine—Muscle spasms—Furosemide—dilated cardiomyopathy	0.000984	0.00267	CcSEcCtD
Clomipramine—Depression—Lisinopril—dilated cardiomyopathy	0.00098	0.00266	CcSEcCtD
Clomipramine—Vomiting—Spironolactone—dilated cardiomyopathy	0.000976	0.00265	CcSEcCtD
Clomipramine—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.000969	0.00263	CcSEcCtD
Clomipramine—Rash—Spironolactone—dilated cardiomyopathy	0.000968	0.00262	CcSEcCtD
Clomipramine—Dermatitis—Spironolactone—dilated cardiomyopathy	0.000967	0.00262	CcSEcCtD
Clomipramine—Vision blurred—Furosemide—dilated cardiomyopathy	0.000964	0.00261	CcSEcCtD
Clomipramine—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.000963	0.00261	CcSEcCtD
Clomipramine—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.000963	0.00261	CcSEcCtD
Clomipramine—Headache—Spironolactone—dilated cardiomyopathy	0.000962	0.00261	CcSEcCtD
Clomipramine—Jaundice—Lisinopril—dilated cardiomyopathy	0.000958	0.0026	CcSEcCtD
Clomipramine—Urinary tract infection—Lisinopril—dilated cardiomyopathy	0.000955	0.00259	CcSEcCtD
Clomipramine—Anaemia—Furosemide—dilated cardiomyopathy	0.000946	0.00256	CcSEcCtD
Clomipramine—Sweating—Lisinopril—dilated cardiomyopathy	0.000942	0.00255	CcSEcCtD
Clomipramine—Agitation—Furosemide—dilated cardiomyopathy	0.00094	0.00255	CcSEcCtD
Clomipramine—Haematuria—Lisinopril—dilated cardiomyopathy	0.000937	0.00254	CcSEcCtD
Clomipramine—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	0.000929	0.00252	CcSEcCtD
Clomipramine—Desipramine—SLC22A5—dilated cardiomyopathy	0.000928	0.155	CrCbGaD
Clomipramine—Epistaxis—Lisinopril—dilated cardiomyopathy	0.000927	0.00251	CcSEcCtD
Clomipramine—Sinusitis—Lisinopril—dilated cardiomyopathy	0.000922	0.0025	CcSEcCtD
Clomipramine—Vertigo—Furosemide—dilated cardiomyopathy	0.000919	0.00249	CcSEcCtD
Clomipramine—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.000917	0.00249	CcSEcCtD
Clomipramine—Leukopenia—Furosemide—dilated cardiomyopathy	0.000916	0.00248	CcSEcCtD
Clomipramine—Nausea—Spironolactone—dilated cardiomyopathy	0.000912	0.00247	CcSEcCtD
Clomipramine—Bradycardia—Lisinopril—dilated cardiomyopathy	0.000898	0.00243	CcSEcCtD
Clomipramine—Rhinitis—Lisinopril—dilated cardiomyopathy	0.000884	0.0024	CcSEcCtD
Clomipramine—ABCB1—heart—dilated cardiomyopathy	0.000884	0.00774	CbGeAlD
Clomipramine—Hepatitis—Lisinopril—dilated cardiomyopathy	0.000882	0.00239	CcSEcCtD
Clomipramine—Hallucination—Lisinopril—dilated cardiomyopathy	0.000878	0.00238	CcSEcCtD
Clomipramine—Pharyngitis—Lisinopril—dilated cardiomyopathy	0.000875	0.00237	CcSEcCtD
Clomipramine—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.000871	0.00236	CcSEcCtD
Clomipramine—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.000865	0.00235	CcSEcCtD
Clomipramine—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.000865	0.00234	CcSEcCtD
Clomipramine—Dry mouth—Furosemide—dilated cardiomyopathy	0.000852	0.00231	CcSEcCtD
Clomipramine—Confusional state—Furosemide—dilated cardiomyopathy	0.000842	0.00228	CcSEcCtD
Clomipramine—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.000835	0.00226	CcSEcCtD
Clomipramine—Tinnitus—Lisinopril—dilated cardiomyopathy	0.000822	0.00223	CcSEcCtD
Clomipramine—Shock—Furosemide—dilated cardiomyopathy	0.000822	0.00223	CcSEcCtD
Clomipramine—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.000819	0.00222	CcSEcCtD
Clomipramine—Flushing—Lisinopril—dilated cardiomyopathy	0.000819	0.00222	CcSEcCtD
Clomipramine—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.000818	0.00222	CcSEcCtD
Clomipramine—Skin disorder—Furosemide—dilated cardiomyopathy	0.000811	0.0022	CcSEcCtD
Clomipramine—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.000807	0.00219	CcSEcCtD
Clomipramine—Angiopathy—Lisinopril—dilated cardiomyopathy	0.0008	0.00217	CcSEcCtD
Clomipramine—Anorexia—Furosemide—dilated cardiomyopathy	0.000796	0.00216	CcSEcCtD
Clomipramine—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.000795	0.00216	CcSEcCtD
Clomipramine—Chills—Lisinopril—dilated cardiomyopathy	0.000791	0.00215	CcSEcCtD
Clomipramine—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.000788	0.00214	CcSEcCtD
Clomipramine—Hypotension—Furosemide—dilated cardiomyopathy	0.00078	0.00212	CcSEcCtD
Clomipramine—Alopecia—Lisinopril—dilated cardiomyopathy	0.000779	0.00211	CcSEcCtD
Clomipramine—Mental disorder—Lisinopril—dilated cardiomyopathy	0.000773	0.0021	CcSEcCtD
Clomipramine—Malnutrition—Lisinopril—dilated cardiomyopathy	0.000768	0.00208	CcSEcCtD
Clomipramine—Flatulence—Lisinopril—dilated cardiomyopathy	0.000757	0.00205	CcSEcCtD
Clomipramine—Tension—Lisinopril—dilated cardiomyopathy	0.000753	0.00204	CcSEcCtD
Clomipramine—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.000752	0.00204	CcSEcCtD
Clomipramine—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00075	0.00203	CcSEcCtD
Clomipramine—Nervousness—Lisinopril—dilated cardiomyopathy	0.000746	0.00202	CcSEcCtD
Clomipramine—Back pain—Lisinopril—dilated cardiomyopathy	0.000743	0.00201	CcSEcCtD
Clomipramine—Somnolence—Furosemide—dilated cardiomyopathy	0.000743	0.00201	CcSEcCtD
Clomipramine—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.000738	0.002	CcSEcCtD
Clomipramine—Decreased appetite—Furosemide—dilated cardiomyopathy	0.000726	0.00197	CcSEcCtD
Clomipramine—Vision blurred—Lisinopril—dilated cardiomyopathy	0.000724	0.00196	CcSEcCtD
Clomipramine—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.000721	0.00196	CcSEcCtD
Clomipramine—Fatigue—Furosemide—dilated cardiomyopathy	0.00072	0.00195	CcSEcCtD
Clomipramine—Tremor—Lisinopril—dilated cardiomyopathy	0.000719	0.00195	CcSEcCtD
Clomipramine—Constipation—Furosemide—dilated cardiomyopathy	0.000714	0.00194	CcSEcCtD
Clomipramine—Pain—Furosemide—dilated cardiomyopathy	0.000714	0.00194	CcSEcCtD
Clomipramine—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.000712	0.00193	CcSEcCtD
Clomipramine—Anaemia—Lisinopril—dilated cardiomyopathy	0.00071	0.00192	CcSEcCtD
Clomipramine—Malaise—Lisinopril—dilated cardiomyopathy	0.000692	0.00188	CcSEcCtD
Clomipramine—Vertigo—Lisinopril—dilated cardiomyopathy	0.00069	0.00187	CcSEcCtD
Clomipramine—Syncope—Lisinopril—dilated cardiomyopathy	0.000689	0.00187	CcSEcCtD
Clomipramine—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.000688	0.00187	CcSEcCtD
Clomipramine—Leukopenia—Lisinopril—dilated cardiomyopathy	0.000687	0.00186	CcSEcCtD
Clomipramine—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.000683	0.00185	CcSEcCtD
Clomipramine—Palpitations—Lisinopril—dilated cardiomyopathy	0.000679	0.00184	CcSEcCtD
Clomipramine—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.000675	0.00183	CcSEcCtD
Clomipramine—Cough—Lisinopril—dilated cardiomyopathy	0.00067	0.00182	CcSEcCtD
Clomipramine—Urticaria—Furosemide—dilated cardiomyopathy	0.000664	0.0018	CcSEcCtD
Clomipramine—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00066	0.00179	CcSEcCtD
Clomipramine—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00066	0.00179	CcSEcCtD
Clomipramine—Chest pain—Lisinopril—dilated cardiomyopathy	0.000654	0.00177	CcSEcCtD
Clomipramine—Myalgia—Lisinopril—dilated cardiomyopathy	0.000654	0.00177	CcSEcCtD
Clomipramine—Arthralgia—Lisinopril—dilated cardiomyopathy	0.000654	0.00177	CcSEcCtD
Clomipramine—Anxiety—Lisinopril—dilated cardiomyopathy	0.000651	0.00177	CcSEcCtD
Clomipramine—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.000649	0.00176	CcSEcCtD
Clomipramine—Discomfort—Lisinopril—dilated cardiomyopathy	0.000646	0.00175	CcSEcCtD
Clomipramine—Desipramine—ADRB1—dilated cardiomyopathy	0.000641	0.107	CrCbGaD
Clomipramine—Dry mouth—Lisinopril—dilated cardiomyopathy	0.000639	0.00173	CcSEcCtD
Clomipramine—Confusional state—Lisinopril—dilated cardiomyopathy	0.000632	0.00171	CcSEcCtD
Clomipramine—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.000627	0.0017	CcSEcCtD
Clomipramine—Oedema—Lisinopril—dilated cardiomyopathy	0.000627	0.0017	CcSEcCtD
Clomipramine—Shock—Lisinopril—dilated cardiomyopathy	0.000617	0.00167	CcSEcCtD
Clomipramine—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.000615	0.00167	CcSEcCtD
Clomipramine—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.000614	0.00166	CcSEcCtD
Clomipramine—Tachycardia—Lisinopril—dilated cardiomyopathy	0.000612	0.00166	CcSEcCtD
Clomipramine—Skin disorder—Lisinopril—dilated cardiomyopathy	0.000609	0.00165	CcSEcCtD
Clomipramine—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.000606	0.00164	CcSEcCtD
Clomipramine—Asthenia—Furosemide—dilated cardiomyopathy	0.000599	0.00162	CcSEcCtD
Clomipramine—Anorexia—Lisinopril—dilated cardiomyopathy	0.000597	0.00162	CcSEcCtD
Clomipramine—Pruritus—Furosemide—dilated cardiomyopathy	0.000591	0.0016	CcSEcCtD
Clomipramine—Hypotension—Lisinopril—dilated cardiomyopathy	0.000586	0.00159	CcSEcCtD
Clomipramine—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000571	0.00155	CcSEcCtD
Clomipramine—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.000571	0.00155	CcSEcCtD
Clomipramine—Insomnia—Lisinopril—dilated cardiomyopathy	0.000567	0.00154	CcSEcCtD
Clomipramine—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000563	0.00153	CcSEcCtD
Clomipramine—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000559	0.00151	CcSEcCtD
Clomipramine—Somnolence—Lisinopril—dilated cardiomyopathy	0.000557	0.00151	CcSEcCtD
Clomipramine—Dizziness—Furosemide—dilated cardiomyopathy	0.000552	0.0015	CcSEcCtD
Clomipramine—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000552	0.0015	CcSEcCtD
Clomipramine—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000545	0.00148	CcSEcCtD
Clomipramine—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.000541	0.00147	CcSEcCtD
Clomipramine—Fatigue—Lisinopril—dilated cardiomyopathy	0.00054	0.00146	CcSEcCtD
Clomipramine—Desipramine—ADRB2—dilated cardiomyopathy	0.000539	0.0897	CrCbGaD
Clomipramine—Constipation—Lisinopril—dilated cardiomyopathy	0.000536	0.00145	CcSEcCtD
Clomipramine—Pain—Lisinopril—dilated cardiomyopathy	0.000536	0.00145	CcSEcCtD
Clomipramine—Vomiting—Furosemide—dilated cardiomyopathy	0.000531	0.00144	CcSEcCtD
Clomipramine—Rash—Furosemide—dilated cardiomyopathy	0.000527	0.00143	CcSEcCtD
Clomipramine—Dermatitis—Furosemide—dilated cardiomyopathy	0.000526	0.00143	CcSEcCtD
Clomipramine—Headache—Furosemide—dilated cardiomyopathy	0.000523	0.00142	CcSEcCtD
Clomipramine—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000516	0.0014	CcSEcCtD
Clomipramine—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000512	0.00139	CcSEcCtD
Clomipramine—Urticaria—Lisinopril—dilated cardiomyopathy	0.000498	0.00135	CcSEcCtD
Clomipramine—Nausea—Furosemide—dilated cardiomyopathy	0.000496	0.00135	CcSEcCtD
Clomipramine—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000495	0.00134	CcSEcCtD
Clomipramine—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000495	0.00134	CcSEcCtD
Clomipramine—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000462	0.00125	CcSEcCtD
Clomipramine—Asthenia—Lisinopril—dilated cardiomyopathy	0.00045	0.00122	CcSEcCtD
Clomipramine—Pruritus—Lisinopril—dilated cardiomyopathy	0.000443	0.0012	CcSEcCtD
Clomipramine—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000429	0.00116	CcSEcCtD
Clomipramine—Dizziness—Lisinopril—dilated cardiomyopathy	0.000414	0.00112	CcSEcCtD
Clomipramine—Vomiting—Lisinopril—dilated cardiomyopathy	0.000398	0.00108	CcSEcCtD
Clomipramine—Rash—Lisinopril—dilated cardiomyopathy	0.000395	0.00107	CcSEcCtD
Clomipramine—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000395	0.00107	CcSEcCtD
Clomipramine—Headache—Lisinopril—dilated cardiomyopathy	0.000393	0.00106	CcSEcCtD
Clomipramine—Nausea—Lisinopril—dilated cardiomyopathy	0.000372	0.00101	CcSEcCtD
Clomipramine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	0.000104	0.000875	CbGpPWpGaD
Clomipramine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	0.000104	0.000875	CbGpPWpGaD
Clomipramine—HTR2B—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000104	0.000875	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—SDHA—dilated cardiomyopathy	0.000104	0.000874	CbGpPWpGaD
Clomipramine—ALB—Platelet activation, signaling and aggregation—CD36—dilated cardiomyopathy	0.000104	0.000873	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000104	0.00087	CbGpPWpGaD
Clomipramine—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	0.000102	0.000857	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000102	0.000855	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000102	0.000855	CbGpPWpGaD
Clomipramine—HTR2A—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000101	0.000851	CbGpPWpGaD
Clomipramine—HTR2B—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000101	0.000847	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.0001	0.000843	CbGpPWpGaD
Clomipramine—HTR2A—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	9.87e-05	0.000829	CbGpPWpGaD
Clomipramine—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	9.84e-05	0.000827	CbGpPWpGaD
Clomipramine—ALB—Platelet activation, signaling and aggregation—RAC1—dilated cardiomyopathy	9.79e-05	0.000823	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR ligand binding—AGTR1—dilated cardiomyopathy	9.71e-05	0.000816	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—PSEN2—dilated cardiomyopathy	9.66e-05	0.000812	CbGpPWpGaD
Clomipramine—ALB—Metabolism—ANKRD1—dilated cardiomyopathy	9.66e-05	0.000811	CbGpPWpGaD
Clomipramine—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	9.64e-05	0.00081	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—CXCR3—dilated cardiomyopathy	9.45e-05	0.000795	CbGpPWpGaD
Clomipramine—HTR6—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	9.43e-05	0.000793	CbGpPWpGaD
Clomipramine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	9.25e-05	0.000777	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR ligand binding—ADRB2—dilated cardiomyopathy	9.21e-05	0.000774	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—ADRB1—dilated cardiomyopathy	9.16e-05	0.000769	CbGpPWpGaD
Clomipramine—ALB—Metabolism—TAZ—dilated cardiomyopathy	9.08e-05	0.000763	CbGpPWpGaD
Clomipramine—HRH2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	9.06e-05	0.000761	CbGpPWpGaD
Clomipramine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	9.05e-05	0.000761	CbGpPWpGaD
Clomipramine—HTR2C—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	9.03e-05	0.000759	CbGpPWpGaD
Clomipramine—HTR2C—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	9.03e-05	0.000759	CbGpPWpGaD
Clomipramine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	8.98e-05	0.000754	CbGpPWpGaD
Clomipramine—HTR6—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	8.95e-05	0.000752	CbGpPWpGaD
Clomipramine—ALB—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	8.86e-05	0.000745	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—ANKRD1—dilated cardiomyopathy	8.67e-05	0.000728	CbGpPWpGaD
Clomipramine—HRH2—GPCR downstream signaling—AGT—dilated cardiomyopathy	8.66e-05	0.000727	CbGpPWpGaD
Clomipramine—HTR2C—GPCR ligand binding—AGT—dilated cardiomyopathy	8.65e-05	0.000727	CbGpPWpGaD
Clomipramine—HTR2B—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	8.61e-05	0.000724	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—CXCL2—dilated cardiomyopathy	8.58e-05	0.000721	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—AGTR2—dilated cardiomyopathy	8.58e-05	0.000721	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—AGTR1—dilated cardiomyopathy	8.57e-05	0.00072	CbGpPWpGaD
Clomipramine—GSTP1—Metabolism—GPX1—dilated cardiomyopathy	8.49e-05	0.000713	CbGpPWpGaD
Clomipramine—ABCB1—Allograft Rejection—TNF—dilated cardiomyopathy	8.46e-05	0.000711	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—ANKRD1—dilated cardiomyopathy	8.46e-05	0.000711	CbGpPWpGaD
Clomipramine—HTR2C—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	8.4e-05	0.000706	CbGpPWpGaD
Clomipramine—GSTP1—Metabolism—CD36—dilated cardiomyopathy	8.26e-05	0.000694	CbGpPWpGaD
Clomipramine—ADRA2A—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	8.23e-05	0.000691	CbGpPWpGaD
Clomipramine—HRH2—Signaling by GPCR—RAC1—dilated cardiomyopathy	8.23e-05	0.000691	CbGpPWpGaD
Clomipramine—ALB—Metabolism—SDHA—dilated cardiomyopathy	8.21e-05	0.00069	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—CXCL2—dilated cardiomyopathy	8.2e-05	0.000689	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—AGTR2—dilated cardiomyopathy	8.2e-05	0.000689	CbGpPWpGaD
Clomipramine—HTR2B—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	8.17e-05	0.000687	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—TAZ—dilated cardiomyopathy	8.15e-05	0.000685	CbGpPWpGaD
Clomipramine—HTR2C—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	8.13e-05	0.000684	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—ADRB2—dilated cardiomyopathy	8.13e-05	0.000683	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—CXCR3—dilated cardiomyopathy	7.98e-05	0.00067	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—ANKRD1—dilated cardiomyopathy	7.97e-05	0.00067	CbGpPWpGaD
Clomipramine—ADRA2A—Hemostasis—ITGB1—dilated cardiomyopathy	7.96e-05	0.000669	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—TAZ—dilated cardiomyopathy	7.95e-05	0.000668	CbGpPWpGaD
Clomipramine—HRH2—Signaling by GPCR—AGT—dilated cardiomyopathy	7.86e-05	0.000661	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	7.85e-05	0.000659	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	7.85e-05	0.000659	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—AGTR1—dilated cardiomyopathy	7.82e-05	0.000657	CbGpPWpGaD
Clomipramine—HTR2A—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	7.8e-05	0.000656	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—ADRB1—dilated cardiomyopathy	7.73e-05	0.000649	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—CXCR3—dilated cardiomyopathy	7.63e-05	0.000641	CbGpPWpGaD
Clomipramine—HTR2A—GPCR ligand binding—AGT—dilated cardiomyopathy	7.51e-05	0.000631	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—TAZ—dilated cardiomyopathy	7.5e-05	0.00063	CbGpPWpGaD
Clomipramine—GSTP1—Metabolism—AGT—dilated cardiomyopathy	7.44e-05	0.000625	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—ADRB2—dilated cardiomyopathy	7.42e-05	0.000623	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—PSEN2—dilated cardiomyopathy	7.41e-05	0.000623	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—ADRB1—dilated cardiomyopathy	7.39e-05	0.000621	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—SDHA—dilated cardiomyopathy	7.37e-05	0.000619	CbGpPWpGaD
Clomipramine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	7.3e-05	0.000614	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	7.29e-05	0.000613	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—SDHA—dilated cardiomyopathy	7.19e-05	0.000604	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	7.14e-05	0.0006	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	7.14e-05	0.0006	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—CXCL2—dilated cardiomyopathy	7.12e-05	0.000599	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—AGTR2—dilated cardiomyopathy	7.12e-05	0.000599	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	7.06e-05	0.000594	CbGpPWpGaD
Clomipramine—HTR6—GPCR downstream signaling—RAC1—dilated cardiomyopathy	6.95e-05	0.000584	CbGpPWpGaD
Clomipramine—HTR2C—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	6.95e-05	0.000584	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR ligand binding—AGT—dilated cardiomyopathy	6.83e-05	0.000574	CbGpPWpGaD
Clomipramine—ADRA2A—Hemostasis—CD36—dilated cardiomyopathy	6.79e-05	0.00057	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—SDHA—dilated cardiomyopathy	6.78e-05	0.00057	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—PSEN2—dilated cardiomyopathy	6.77e-05	0.000569	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—ANKRD1—dilated cardiomyopathy	6.75e-05	0.000568	CbGpPWpGaD
Clomipramine—HTR6—GPCR downstream signaling—AGT—dilated cardiomyopathy	6.64e-05	0.000558	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	6.64e-05	0.000558	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—CXCR3—dilated cardiomyopathy	6.62e-05	0.000557	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—AGTR1—dilated cardiomyopathy	6.6e-05	0.000555	CbGpPWpGaD
Clomipramine—HTR2C—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	6.59e-05	0.000554	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—CXCL2—dilated cardiomyopathy	6.58e-05	0.000553	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—AGTR2—dilated cardiomyopathy	6.58e-05	0.000553	CbGpPWpGaD
Clomipramine—ALB—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	6.49e-05	0.000546	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—CXCL2—dilated cardiomyopathy	6.48e-05	0.000545	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—AGTR2—dilated cardiomyopathy	6.48e-05	0.000545	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	6.43e-05	0.00054	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—ADRB1—dilated cardiomyopathy	6.41e-05	0.000539	CbGpPWpGaD
Clomipramine—ADRA2A—Hemostasis—RAC1—dilated cardiomyopathy	6.4e-05	0.000538	CbGpPWpGaD
Clomipramine—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	6.39e-05	0.000537	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—TAZ—dilated cardiomyopathy	6.35e-05	0.000534	CbGpPWpGaD
Clomipramine—HTR2B—GPCR downstream signaling—RAC1—dilated cardiomyopathy	6.34e-05	0.000533	CbGpPWpGaD
Clomipramine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	6.34e-05	0.000533	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—RAC1—dilated cardiomyopathy	6.31e-05	0.00053	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—AGTR1—dilated cardiomyopathy	6.31e-05	0.00053	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—ITGB1—dilated cardiomyopathy	6.28e-05	0.000528	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—ADRB2—dilated cardiomyopathy	6.26e-05	0.000526	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—CXCR3—dilated cardiomyopathy	6.12e-05	0.000514	CbGpPWpGaD
Clomipramine—HTR2B—GPCR downstream signaling—AGT—dilated cardiomyopathy	6.06e-05	0.000509	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	6.03e-05	0.000507	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—AGT—dilated cardiomyopathy	6.03e-05	0.000507	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—CXCR3—dilated cardiomyopathy	6.03e-05	0.000506	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—CXCL2—dilated cardiomyopathy	6.01e-05	0.000505	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—AGTR2—dilated cardiomyopathy	6.01e-05	0.000505	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—ADRB2—dilated cardiomyopathy	5.99e-05	0.000503	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—ADRB1—dilated cardiomyopathy	5.93e-05	0.000498	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—ADRB1—dilated cardiomyopathy	5.84e-05	0.00049	CbGpPWpGaD
Clomipramine—SLC6A2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	5.77e-05	0.000485	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—RAC1—dilated cardiomyopathy	5.76e-05	0.000484	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—SDHA—dilated cardiomyopathy	5.74e-05	0.000483	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	5.72e-05	0.000481	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—CXCR3—dilated cardiomyopathy	5.59e-05	0.000469	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—AGT—dilated cardiomyopathy	5.5e-05	0.000462	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	5.49e-05	0.000461	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	5.48e-05	0.00046	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—PSEN2—dilated cardiomyopathy	5.46e-05	0.000459	CbGpPWpGaD
Clomipramine—HRH2—Signaling by GPCR—RAF1—dilated cardiomyopathy	5.46e-05	0.000458	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—ADRB1—dilated cardiomyopathy	5.41e-05	0.000455	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	5.38e-05	0.000452	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—CD36—dilated cardiomyopathy	5.36e-05	0.00045	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	5.21e-05	0.000438	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	5.21e-05	0.000438	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	5.2e-05	0.000437	CbGpPWpGaD
Clomipramine—HTR2C—GPCR downstream signaling—RAC1—dilated cardiomyopathy	5.12e-05	0.00043	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—AGTR1—dilated cardiomyopathy	5.06e-05	0.000425	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—RAC1—dilated cardiomyopathy	5.05e-05	0.000424	CbGpPWpGaD
Clomipramine—ALB—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	5.01e-05	0.000421	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	4.98e-05	0.000419	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	4.9e-05	0.000412	CbGpPWpGaD
Clomipramine—HTR2C—GPCR downstream signaling—AGT—dilated cardiomyopathy	4.89e-05	0.000411	CbGpPWpGaD
Clomipramine—ALB—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	4.88e-05	0.00041	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—RAC1—dilated cardiomyopathy	4.86e-05	0.000408	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—CXCL2—dilated cardiomyopathy	4.85e-05	0.000407	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—AGTR2—dilated cardiomyopathy	4.85e-05	0.000407	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—ADRB2—dilated cardiomyopathy	4.8e-05	0.000403	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—PSEN2—dilated cardiomyopathy	4.74e-05	0.000398	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	4.73e-05	0.000397	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—RAC1—dilated cardiomyopathy	4.65e-05	0.00039	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—AGT—dilated cardiomyopathy	4.64e-05	0.00039	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—AGTR1—dilated cardiomyopathy	4.62e-05	0.000388	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—CXCR3—dilated cardiomyopathy	4.51e-05	0.000379	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	4.5e-05	0.000378	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	4.44e-05	0.000373	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—AGT—dilated cardiomyopathy	4.44e-05	0.000373	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	4.43e-05	0.000372	CbGpPWpGaD
Clomipramine—ALB—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	4.39e-05	0.000369	CbGpPWpGaD
Clomipramine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	4.38e-05	0.000368	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—ADRB2—dilated cardiomyopathy	4.38e-05	0.000368	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	4.38e-05	0.000368	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—ADRB1—dilated cardiomyopathy	4.36e-05	0.000367	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—PSEN2—dilated cardiomyopathy	4.31e-05	0.000362	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—AGT—dilated cardiomyopathy	4.25e-05	0.000357	CbGpPWpGaD
Clomipramine—ADRA2A—Hemostasis—RAF1—dilated cardiomyopathy	4.24e-05	0.000356	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—AGTR2—dilated cardiomyopathy	4.21e-05	0.000354	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—CXCL2—dilated cardiomyopathy	4.21e-05	0.000354	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—RAF1—dilated cardiomyopathy	4.18e-05	0.000352	CbGpPWpGaD
Clomipramine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	4.18e-05	0.000351	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.13e-05	0.000347	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	4.04e-05	0.00034	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—RAC1—dilated cardiomyopathy	4.04e-05	0.000339	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	3.94e-05	0.000331	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—CXCR3—dilated cardiomyopathy	3.91e-05	0.000329	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—AGT—dilated cardiomyopathy	3.86e-05	0.000325	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—AGT—dilated cardiomyopathy	3.86e-05	0.000324	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—AGTR2—dilated cardiomyopathy	3.83e-05	0.000322	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—CXCL2—dilated cardiomyopathy	3.83e-05	0.000322	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—RAF1—dilated cardiomyopathy	3.82e-05	0.000321	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—ADRB1—dilated cardiomyopathy	3.79e-05	0.000318	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	3.77e-05	0.000316	CbGpPWpGaD
Clomipramine—HRH2—Signaling by GPCR—EGFR—dilated cardiomyopathy	3.74e-05	0.000314	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—RAC1—dilated cardiomyopathy	3.73e-05	0.000313	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—AGTR1—dilated cardiomyopathy	3.73e-05	0.000313	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—RAC1—dilated cardiomyopathy	3.67e-05	0.000308	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—AGT—dilated cardiomyopathy	3.56e-05	0.000299	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—CXCR3—dilated cardiomyopathy	3.56e-05	0.000299	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—ADRB2—dilated cardiomyopathy	3.54e-05	0.000297	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—AGT—dilated cardiomyopathy	3.51e-05	0.000295	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	3.5e-05	0.000294	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—ADRB1—dilated cardiomyopathy	3.45e-05	0.00029	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	3.41e-05	0.000287	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—RAC1—dilated cardiomyopathy	3.4e-05	0.000286	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—RAF1—dilated cardiomyopathy	3.35e-05	0.000281	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—AGT—dilated cardiomyopathy	3.25e-05	0.000273	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—AGTR1—dilated cardiomyopathy	3.24e-05	0.000272	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—RAF1—dilated cardiomyopathy	3.22e-05	0.000271	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—RAF1—dilated cardiomyopathy	3.08e-05	0.000259	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	3.07e-05	0.000258	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—ADRB2—dilated cardiomyopathy	3.07e-05	0.000258	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	3.04e-05	0.000255	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—AGTR1—dilated cardiomyopathy	2.94e-05	0.000247	CbGpPWpGaD
Clomipramine—ALB—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.9e-05	0.000244	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.87e-05	0.000241	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—GPX1—dilated cardiomyopathy	2.83e-05	0.000237	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—ADRB2—dilated cardiomyopathy	2.79e-05	0.000235	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—CD36—dilated cardiomyopathy	2.75e-05	0.000231	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—RAC1—dilated cardiomyopathy	2.74e-05	0.000231	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—RAF1—dilated cardiomyopathy	2.68e-05	0.000225	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.64e-05	0.000222	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—AGT—dilated cardiomyopathy	2.62e-05	0.00022	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.62e-05	0.00022	CbGpPWpGaD
Clomipramine—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.54e-05	0.000213	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—AGT—dilated cardiomyopathy	2.48e-05	0.000208	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—RAF1—dilated cardiomyopathy	2.47e-05	0.000208	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—RAF1—dilated cardiomyopathy	2.43e-05	0.000205	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.4e-05	0.000202	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—RAC1—dilated cardiomyopathy	2.38e-05	0.0002	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—AGT—dilated cardiomyopathy	2.28e-05	0.000191	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—RAF1—dilated cardiomyopathy	2.26e-05	0.00019	CbGpPWpGaD
Clomipramine—ALB—Metabolism—GPX1—dilated cardiomyopathy	2.23e-05	0.000187	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—EGFR—dilated cardiomyopathy	2.21e-05	0.000186	CbGpPWpGaD
Clomipramine—ALB—Metabolism—CD36—dilated cardiomyopathy	2.17e-05	0.000183	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—RAC1—dilated cardiomyopathy	2.17e-05	0.000182	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.11e-05	0.000178	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—AGT—dilated cardiomyopathy	2.07e-05	0.000174	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—GPX1—dilated cardiomyopathy	2e-05	0.000168	CbGpPWpGaD
Clomipramine—ALB—Metabolism—AGT—dilated cardiomyopathy	1.96e-05	0.000164	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	1.95e-05	0.000164	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—CD36—dilated cardiomyopathy	1.95e-05	0.000164	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—CD36—dilated cardiomyopathy	1.9e-05	0.00016	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—GPX1—dilated cardiomyopathy	1.84e-05	0.000155	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.83e-05	0.000154	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—RAF1—dilated cardiomyopathy	1.82e-05	0.000153	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—CD36—dilated cardiomyopathy	1.79e-05	0.000151	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—AGT—dilated cardiomyopathy	1.76e-05	0.000148	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—AGT—dilated cardiomyopathy	1.71e-05	0.000144	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—EGFR—dilated cardiomyopathy	1.69e-05	0.000142	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.67e-05	0.00014	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—AGT—dilated cardiomyopathy	1.61e-05	0.000136	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—RAF1—dilated cardiomyopathy	1.58e-05	0.000133	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—GPX1—dilated cardiomyopathy	1.56e-05	0.000131	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—EGFR—dilated cardiomyopathy	1.55e-05	0.00013	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—CD36—dilated cardiomyopathy	1.52e-05	0.000128	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—RAF1—dilated cardiomyopathy	1.44e-05	0.000121	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—AGT—dilated cardiomyopathy	1.37e-05	0.000115	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—EGFR—dilated cardiomyopathy	1.25e-05	0.000105	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	1.2e-05	0.000101	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	1.17e-05	9.85e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—EGFR—dilated cardiomyopathy	1.08e-05	9.11e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	1.06e-05	8.87e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—EGFR—dilated cardiomyopathy	9.86e-06	8.29e-05	CbGpPWpGaD
